Related Experiment Videos

Elevated CA125 levels in patients with metastatic breast carcinoma

L Perey¹, D F Hayes, C Tondini

¹Service d'Oncologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

British Journal of Cancer

|October 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer.

ESMO open·2025

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Ontology-Driven Real World Evidence Extraction from Clinical Narratives.

Studies in health technology and informatics·2019

See all related articles